Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this protocol is to evaluate 12 weeks of treatment of varenicline
compared to placebo for smoking cessation. Abstinence from cigarette smoking and other
tobacco products (e.g., pipe, cigars, chew, snuff.) use during non-treatment follow-up period
will also be evaluated.